Steven Barg
Known title: DirectorCIK: 0001852883
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Cardinal Health Hits Record Highs as Sector Strength Continues. Cardinal Health's stock has reached record highs, outperforming the broader market as the healthcare sector shows strong momentum. In corporate news, Senior Vice President Shane Abeyratne has joined the Customer Experience Advisory Board of Level AI. Meanwhile, market observers are looking ahead to the company's upcoming Q1 2027 earnings report and its position as a defensive option in the current economic environment.
Transaction History
| CRL | ▲ Buy | Grant | 422 | $74K | 6/2/2026 | View on chart |
| CRL | ▲ Buy | Grant | 1,438 | $255K | 5/8/2026 | View on chart |
| CRL | ▲ Buy | Grant | 481 | $65K | 6/2/2025 | View on chart |
| CRL | ▲ Buy | Grant | 946 | $128K | 6/2/2025 | View on chart |
| CAH | ▲ Buy | Grant | 1,965 | $0 | 11/15/2023 | View on chart |
| CAH | ▲ Buy | Grant | 2,308 | $0 | 11/9/2022 | View on chart |
| CAH | ▲ Buy | Grant | 466 | $0 | 9/15/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 4, 2026
CRL Analyst Targets Rise After UBS Reinstates Coverage
Charles River Laboratories saw its average analyst price target increase to $305.00, driven by UBS reinstating coverage with a $357.00 target. This move follows reports of stabilizing demand and increased interest in animal model markets. The stock is currently trading below its 52-week high, with technical indicators showing support near $181.76.
CRL Analyst Targets Rise After UBS Reinstates Coverage. Charles River Laboratories saw its average analyst price target increase to $305.00, driven by UBS reinstating coverage with a $357.00 target. This move follows reports of stabilizing demand and increased interest in animal model markets. The stock is currently trading below its 52-week high, with technical indicators showing support near $181.76.